Today: 9 April 2026

Bitfarms Stock Explodes on Crypto & AI Boom – 148% YTD Rally

Bitfarms Stock Explodes on Crypto & AI Boom – 148% YTD Rally

Bitfarms shares closed near $4.00 on NASDAQ and C$5.65 on TSX, up 148% year-to-date and hitting a new 52-week high. Q2 2025 revenue reached $78 million, but the company posted a $29 million net loss. Bitfarms operates 13 largely hydro-powered data centers and is expanding into HPC/AI with a new U.S. site plan. Analysts rate the stock a “Moderate Buy,” though targets sit below current prices.
AtlasClear (ATCH) Stock Skyrockets 50% on $20M Financing – Fintech Underdog Poised to Soar?

AtlasClear (ATCH) Stock Skyrockets 50% on $20M Financing – Fintech Underdog Poised to Soar?

AtlasClear (ATCH) closed at $0.36 on Oct. 8, 2025, with a 52-week range of $0.14–$26.94 and short interest near 28%. The company announced a $20M financing on Oct. 9, led by Funicular Funds, after closing a $5M round in September. AtlasClear reported FY2025 revenues of about $10–11M and negative margins, following an 83% reduction in debt. It plans to acquire Commercial Bancorp of Wyoming.
9 October 2025
Shocking IRS Update: New 2026 Tax Brackets Slashed for Millions – Here’s How Much You’ll Save

Shocking IRS Update: New 2026 Tax Brackets Slashed for Millions – Here’s How Much You’ll Save

The IRS released 2026 tax brackets and deductions, raising the standard deduction to $32,200 for joint filers and $16,100 for singles. All income thresholds shift higher, with a single earner making $50,000 now taxed at 12% instead of 22%. Marginal rates remain at 10%–37%. The changes follow the “One Big Beautiful Bill” signed in July 2025, which made most 2017 tax cuts permanent.
9 October 2025
CIFR Stock Skyrockets 320% After Google-Backed AI Mining Deal – Bubble or Boom?

CIFR Stock Skyrockets 320% After Google-Backed AI Mining Deal – Bubble or Boom?

Cipher Mining shares closed at $17.60 on Oct. 8, up nearly 12% after announcing a $3 billion, Google-backed AI hosting deal at its new Barber Lake site. The company’s market cap stands near $6 billion, with the stock up over 320% year-to-date. Cipher remains unprofitable, reporting a Q2 net loss of $46 million on $44 million revenue. Former CFO Ed Farrell retired Oct. 14, replaced by Greg Mumford.
MEDIROM (NASDAQ: MRM) Set for Takeoff: Series A Boost & Altman-Backed ‘Orb’ Deal Fuels 150% Upside

MEDIROM (NASDAQ: MRM) Set for Takeoff: Series A Boost & Altman-Backed ‘Orb’ Deal Fuels 150% Upside

MRM shares surged 22% pre-market Oct. 9 after MOTHER Labs secured Series A funding at a ¥9 billion valuation. In late September, MEDIROM partnered with World to deploy World ID Orb devices in 100 Re.Ra.Ku salons, the largest rollout in Japan. Its REMONY system received Japanese government certification in August and was adopted by the Ground Self-Defense Force. MEDIROM posted 2024 revenue of $52.74M, up 22%.
Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Akero shares jumped nearly 19% to $55 on October 9, 2025 after Novo Nordisk announced a $5.2 billion buyout at $54 per share plus a $6 contingent payment. Novo will pay $4.7 billion upfront and another $500 million if Akero’s lead drug, efruxifermin, wins FDA approval by 2031. The deal has board approval and is expected to close by late 2025, pending regulatory and shareholder clearance.
Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics shares surged to around $23 midday Oct. 9 after opening at $24.50, following a prior close of $7. Market cap jumped to over $500 million from under $100 million. The stock debuted on Nasdaq Oct. 8 via direct listing and has traded with extreme volatility, more than tripling in value amid speculative interest. No new FDA approvals were announced this week.
Intellia Therapeutics Stock Soars on Gene-Editing Breakthrough – Analysts Eye 70–100% Upside

Intellia Therapeutics Stock Soars on Gene-Editing Breakthrough – Analysts Eye 70–100% Upside

NTLA surged past $26 on Oct. 8, 2025, after positive Phase 1 data for its ATTR program showed sustained TTR protein knockdown and no new safety issues. Trading volume spiked to 17 million shares. Wall Street remains bullish, with most analysts rating NTLA a Buy and targets averaging $31.7. Intellia holds $630–707 million in cash and expects funding to last into 2027.
Uzbekistan’s Big Bet: Import Fair 2025 Sparks a ‘Made in Uzbekistan’ Boom

Uzbekistan’s Big Bet: Import Fair 2025 Sparks a ‘Made in Uzbekistan’ Boom

Uzbekistan launched its first international Import Fair in Tashkent, unveiling $8.5 billion in new investment projects to boost local manufacturing and reduce imports. At the same time, 66 Uzbek firms promoted exports at MSV-2025 in Brno. GDP rose 7.2% year-on-year in early 2025, with FDI reaching $11.9 billion in 2024. Major foreign companies, including Inditex, praised recent trade reforms.
9 October 2025
United Airlines Stock Skyrockets on Travel Boom: Is $130 Next for UAL?

United Airlines Stock Skyrockets on Travel Boom: Is $130 Next for UAL?

United Airlines shares closed at $98.09 on Oct 8, 2025, up 1.5%, and surged to $104 in early trading Oct 9. The stock rebounded from $94 lows last week, tracking sector gains after Delta’s strong Q3 results. United announced new European and Middle Eastern routes for summer 2026. The ongoing U.S. government shutdown has caused flight delays but has not yet disrupted airline operations.
9 October 2025
Bluejay Diagnostics (BJDX) Stock Skyrockets on Sepsis Test Hopes – What Investors Need to Know

Bluejay Diagnostics (BJDX) Stock Skyrockets on Sepsis Test Hopes – What Investors Need to Know

Bluejay Diagnostics shares soared over 142% to $4.53 on Oct. 9 after announcing an expanded manufacturing partnership with SanyoSeiko. Trading volume hit 40 million shares, far above the 154,000 average. The company, which has no product revenue and only $5.7 million in cash, recently cut its workforce by 90%. Symphony, its lead diagnostic product, is not yet FDA-cleared.
American Airlines (AAL) Stock Takes Off on Travel Demand – Will It Keep Climbing or Hit Turbulence?

American Airlines (AAL) Stock Takes Off on Travel Demand – Will It Keep Climbing or Hit Turbulence?

American Airlines shares traded near $12 on Oct. 9, 2025, down 34% year-to-date and 15% in the past month. The stock rose 3–4% after Delta’s strong Q3 results, but American still faces weak domestic demand, high debt, and rising labor costs. Analysts remain split, with price targets ranging from $8 to $17. The company will report Q3 earnings later this month.
9 October 2025
Serve Robotics (SERV) Stock Soars on DoorDash Deal – The Next Big Bet in AI Delivery?

Serve Robotics (SERV) Stock Soars on DoorDash Deal – The Next Big Bet in AI Delivery?

Serve Robotics announced a partnership with DoorDash on October 9, 2025, to deploy its autonomous delivery robots in Los Angeles. The news sent SERV shares up 15% in one day. The company, which went public in April 2024, operates about 400 robots and plans to expand to 2,000 by year-end. Serve’s market cap stands near $800 million, though annual revenue remains under $2 million.
Jefferies Scrambles as First Brands’ $10 Billion Bankruptcy Reveals $2.3 Billion in ‘Vanished’ Debt

Jefferies Scrambles as First Brands’ $10 Billion Bankruptcy Reveals $2.3 Billion in ‘Vanished’ Debt

First Brands Group, supplier of TRICO wipers and FRAM filters, filed for Chapter 11 bankruptcy on Sept. 28, 2025, listing $10–$50 billion in liabilities and $1–$10 billion in assets. The collapse exposed nearly $2 billion in hidden debt and up to $2.3 billion missing from supply-chain financing. Jefferies Financial Group faces $715 million in exposure, with its shares down 14% in a week. A court probe is underway into possible misconduct.
9 October 2025
Powell’s Next Move Could Make or Break 2025’s Record Stock Rally

Powell’s Next Move Could Make or Break 2025’s Record Stock Rally

The S&P 500 and Nasdaq closed at record highs on Oct. 8, with the S&P up 0.6% to 6,753.72 and the Nasdaq rising 1.1% to 23,043.38. Gold surged past $4,000/oz for the first time, peaking at $4,078 before retreating slightly. Tech stocks soared, led by AMD’s 24% jump after an OpenAI deal. The Fed signaled more rate cuts after its first 2025 reduction, though inflation concerns remain.
Nvidia’s $2B Bet on Reflection AI Shakes Up the Global AI Race

Nvidia’s $2B Bet on Reflection AI Shakes Up the Global AI Race

Reflection AI has raised $2 billion in new funding led by Nvidia, boosting its valuation to about $8 billion from $545 million in March. Founded in 2024 by ex-DeepMind researchers, the startup is developing open-source AI models to rival China’s DeepSeek. Nvidia reportedly invested up to $500 million, with backing from Lightspeed, Sequoia, DST Global, and 1789 Capital. The round was oversubscribed amid intense investor demand.
Wolfspeed WOLF Stock’s Wild Comeback: From Bankruptcy to Boom – Price, News & Expert Forecasts

Wolfspeed WOLF Stock’s Wild Comeback: From Bankruptcy to Boom – Price, News & Expert Forecasts

Wolfspeed stock surged over 1,000% intraday on September 29, 2025, after emerging from Chapter 11 bankruptcy and slashing debt by about 70%. Shares traded near $30.36 on October 9, giving a market cap of $0.7–0.8 billion. Most old equity was wiped out, with existing shareholders retaining only 3–5% of the company. Analysts rate the stock a Hold, with average 12-month price targets of $8–10.
9 October 2025

Stock Market Today

  • Ares Management (ARES) Share Price Drops 37% YTD, Valuation Concerns Raised
    April 8, 2026, 8:05 PM EDT. Ares Management's (ARES) shares have fallen 37% year-to-date despite solid long-term gains, highlighting shifting investor sentiment in alternative asset managers. The stock trades around $104.83, but valuation models suggest a lower intrinsic value of $87.61, implying a 19.7% overvaluation. Metrics like book value ($12.68 per share) and earnings per share ($5.79) underpin this analysis. Ares' high return on equity (27.6%) contrasts with a cost of equity at $1.93, yet excess returns indicate value creation may not justify the current share price. Investors are advised to weigh fee-based revenue models against market risk reassessments. Simply Wall St rates ARES 0/6 on valuation checks, signaling caution amid volatile market conditions.

Latest article

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Alphabet Stock (GOOG, GOOGL) Faces Split Fund Bets Ahead of Earnings After Fresh 13F Reports

Alphabet Stock (GOOG, GOOGL) Faces Split Fund Bets Ahead of Earnings After Fresh 13F Reports

8 April 2026
Zevenbergen Capital increased its Alphabet Class A share holdings by 27.4% in Q4, while Lombard Odier and Empirical Wealth Management reduced their Class C positions, according to April 7 filings. Alphabet will report first-quarter results on April 29. GOOG and GOOGL traded near $304 before Wednesday’s U.S. open. The filings reflect holdings as of December 31 and may not show current positions.
Go toTop